Professional Staff

Noam Kirson

Vice President

Boston
Tel: 617-425-8246
Fax: 617-425-8001
noam.kirson@analysisgroup.com

Education:
Ph.D., economics, Harvard University; B.A., philosophy, political science, economics, Hebrew University
Summary of Experience:
Dr. Kirson is an applied microeconomist who specializes in health economics, antitrust, and the application of econometrics and advanced statistical methods. He has considerable experience both in complex litigation matters and in health economics and outcomes research (HEOR). His litigation case work has included evaluation of antitrust matters in the health care, technology, and credit card sectors; assessment of alleged improper marketing practices in the pharmaceutical industry; and a variety of commercial litigation and damages projects. In the HEOR space, Dr. Kirson has managed numerous health outcomes projects, including cost-of-illness studies, comparative effectiveness research, cost-effectiveness evaluations, and development of advanced modeling tools. His work has spanned a variety of disease and treatment areas, including Alzheimer’s disease, prescription opioid abuse, schizophrenia, neuropathic pain, pulmonary hypertension, and autoimmune diseases, and has resulted in multiple conference presentations and publications. His work has been published in Alzheimer’s & Dementia, the Journal of Clinical Psychiatry, and Health Affairs, as well as various pharmacoeconomic journals.

ASSESSING THE ECONOMIC BURDEN OF ALZHEIMER’S DISEASE 

Research by Dr. Kirson and several other Analysis Group researchers suggests that consulting with a specialist at the early stages of cognitive decline may result in reduced spending for medical services.